Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Daniel Durrie

Ophthalmology Overland Park, KS Medical Doctor

NPI 1952305526 CMS profile 133252

5520 College Blvd 201, Overland Park, KS 66211

Open in the dashboard

General payments

$974,481

50 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$59,346

3 holdings reported · through program year 2024

Through program year 2024, Daniel Durrie of Overland Park, KS is reported in the CMS Open Payments database as having received $974,481 across 50 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $59,346 across 3 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Ophthalmology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $726,001 2
2023 General $210,177 6
2022 General $9,147 2
2021 General $889 4
2020 General $12,362 13
2019 General $15,905 23
2022 Ownership $38,656 1
2021 Ownership $10,890 1
2020 Ownership $9,800 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Daniel Durrie
  • Ophthalmology median
  • Middle half of Ophthalmology
  • National median

In program year 2025, general payments to Daniel Durrie were reported at $0. Among 13,034 Ophthalmology profiles paid that year, the median was $384 and the middle half received between $136 and $917.

Show as a table
Year Daniel Durrie Ophthalmology median Middle half National median
2019 $15,905 $258 $104–$655 $163
2020 $12,362 $126 $45–$321 $114
2021 $889 $205 $76–$534 $132
2022 $9,147 $266 $100–$678 $149
2023 $210,177 $308 $117–$745 $160
2024 $726,001 $340 $127–$846 $164
2025 $0 $384 $136–$917 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. RxSight Inc $934,709 3 payments
  2. Johnson & Johnson Surgical Vision, Inc. $34,212 27 payments
  3. Avedro Inc. $2,750 1 payment
  4. Alcon Vision LLC $1,445 5 payments
  5. Alcon Research LLC $700 1 payment
  6. Carl Zeiss Meditec, Inc. $358 6 payments
  7. Staar Surgical Company $162 4 payments
  8. Beaver-Visitec International, Inc. $74 1 payment
  9. Bausch & Lomb Americas Inc. $47 1 payment
  10. Novartis Pharmaceuticals Corporation $24 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $934,709 3 payments
  2. Consulting Fee $36,200 10 payments
  3. Travel and Lodging $1,982 5 payments
  4. Food and Beverage $1,590 32 payments
Products named General payments · program years 2019–2024
  1. RXSIGHT CONTACT LENS $934,709 3 payments
  2. RXSIGHT INJECTOR CARTRIDGE $934,709 3 payments
  3. RXSIGHT INJECTOR HANDPIECE $934,709 3 payments
  4. RXSIGHT LIGHT DELIVERY DEVICE (LDD) $934,709 3 payments
  5. LIGHT ADJUSTABLE LENS (LAL) $726,001 2 payments
  6. RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL) $208,709 1 payment
  7. Catalys Laser System $20,577 15 payments
  8. COMPACT INTUITIV Phacofragmentation System $18,615 4 payments
  9. iDesign Advanced Wavescan Studio $10,815 4 payments
  10. iFS Advanced Femtosecond Laser $10,815 4 payments
  11. Other $51,433 54 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

50 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Ophthalmology in Kansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record